ReportsWeb- Partnerships Licensing Investments and M&A Deals a | Page 2

payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America,
and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key
advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001866660/sample
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements;
divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone
payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech
companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing
agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and
partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for
acquisitions within the industry.
Table of Content:
1.1 List of Tables 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary 10
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 16
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, April 2017 36
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 45
6 Deal Summary by Geography 60
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 70
8 Further Information 72